Stomach neoplasms Clinical Trials
Conditions / Stomach neoplasms
Delta Trials records 202 clinical trials for Stomach neoplasms in its publicly accessible dataset. From the full dataset, 22 actively seeking eligible participants and 89 trials have reached completion. This research is conducted across 540 study locations around the world. An additional 91 trials are active but not currently open for enrollment. Since 2020, 13 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
202
Total Trials
22
Recruiting
89
Completed
91
Other Active
13
Terminated since 2020
540
Study Locations
Browse by location (540 total)
- Seoul, South Korea 31 trialsAll trials in Seoul, South Korea
- Guangzhou, China 19 trialsAll trials in Guangzhou, China
- Beijing, China 15 trialsAll trials in Beijing, China
- Fuzhou, China 15 trialsAll trials in Fuzhou, China
- Barcelona, Spain 12 trialsAll trials in Barcelona, Spain
- Shanghai, China 11 trialsAll trials in Shanghai, China
- Madrid, Spain 10 trialsAll trials in Madrid, Spain
- Goyang-si, South Korea 10 trialsAll trials in Goyang-si, South Korea
- Taipei, Taiwan 10 trialsAll trials in Taipei, Taiwan
- Taipei, Taiwan 10 trialsAll trials in Taipei, Taiwan
- Nanjing, China 9 trialsAll trials in Nanjing, China
- London, United Kingdom 9 trialsAll trials in London, United Kingdom
- Milan, Italy 8 trialsAll trials in Milan, Italy
- Toronto, Canada 8 trialsAll trials in Toronto, Canada
- Kashiwa, Japan 7 trialsAll trials in Kashiwa, Japan
- Villejuif, France 7 trialsAll trials in Villejuif, France
- New York, United States 7 trialsAll trials in New York, United States
- Houston, United States 7 trialsAll trials in Houston, United States
- Boston, United States 6 trialsAll trials in Boston, United States
- Amsterdam, Netherlands 6 trialsAll trials in Amsterdam, Netherlands